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Animal models of endocarditis have helped understanding of the mode of action of antibiotics in prophylaxis. During bac-
teraemia, some microorganisms will adhere to damaged cardiac valves. The proportion of bacteria that will adhere depends
largely on intrinsic properties of the strain. In the absence of antibiotics, the microorganisms will either be eliminated by local
host defence mechanisms if the inoculum is low enough or will begin to grow approximately 2 h after the development of
bacteraemia and endocarditis. In the presence of antibiotics, the growth of adherent bacteria is inhibited and local host
defences have longer to eliminate the bacteria. In cases where the number of adherent bacteria is relatively low, a short period
in inhibitory antibiotic activity (6 hours) is sufficient to eliminate the bacteria and lead to successful prophylaxis. If the num-
ber of bacteria is high, a longer duration of the inhibitory effect is necessary. These experimental data provide a rationale for
practical recommendations for the prophylaxis of endocarditis in humans.
Introduction
Recommendations for the antibiotic prophylaxis of endo-
carditis are updated periodically in order to fit new data
and practices. Unfortunately, there is no prospective clini-
cal trial on the efficacy of prophylactic antibiotics in endo-
carditis, and it is unlikely that such a study will ever be
performed, both for ethical and practical reasons. TVvo
case-control studies have shown a prophylactic efficacy of
antibiotics of 49% and 91%, in patients with native
valves'1-21. A French study showed no protective efficacy131.
In another study of patients with prosthetic valves and a
multiple-dose prophylactic regimen, six cases of endo-
carditis were recorded following 390 invasive procedures
performed without antibiotic prophylaxis whereas none
were recorded among 285 procedures performed with
antibiotic prophylaxis, a difference which was statistically
significant'41. These divergent results may partially be
explained by the characteristics of the antibiotic regimens
used. At present, most European countries recommend a
single oral dose of 3 g of amoxicillin to be taken 1 hour
before a procedure. In contrast, the American Heart
Association recommend a second dose of 1-5 g of amoxi-
cillin, to be given 6 h after the first'5'. Some countries,
including Switzerland, differentiate between moderate-
and high-risk patients (prosthetic valves, prior endocar-
ditis) and recommend multiple doses of antibiotics only for
the high-risk patients'61. There are no human data to sup-
port any particular one of these various approaches.
However, experimental models provide helpful informa-
tion for practical recommendations.
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Role of the inoculum size
In their early experiments on rabbits, Durack and his
colleagues injected i.v. 10s colony-forming units (cfu) of
viridans streptococci and enterococci, an inoculum size
that produced endocarditis in 100% of the control
animals'71. In fact, this number of bacteria was probably 10
to 100 times higher than the lowest infecting dose neces-
sary to produce endocarditis in 90% of the rabbits (IDgo).
Various regimens of prophylactic antibiotics were tested
under these stringent experimental conditions and as
results suggested that prolonged administration of high
doses of antibiotics were necessary for successful prophy-
laxis, multiple dose regimens were recommended in
humans'81. These experiments were criticized because of
the high inoculum used, which was thought to be irrelevant
to the human situation. In experiments performed more
recently in the rat model of endocarditis, the efficacy of the
prophylactic antibiotics was found to be dependent on the
inoculum size used for the bacterial challenge: protection
was excellent with single dose of antibiotics for inocula not
higher than the ID90 but disappeared with higher inocula'91.
As observed by Durack and colleagues, protection was re-
established in the multiple doses of antibiotics'101. These
results were thought to provide a good rationale for single
dose prophylaxis regimens, as very high inocula were
unlikely to apply to human situations. The magnitude of
bacteraemia observed in humans after certain procedures
such as teeth extraction is generally of the order of 101 to
102 cfu.mr1 of blood for a given strain'11'. However, it
should be stressed that the number of bacteria injected i.v.
into animals does not represent the number of bacteria that
circulate, due to both a passive haemodilution and an
active clearance mechanism by the reticulo-endothelial
system'121. In addition, studies on endocarditis in rats with
periodontitis and after teeth extraction have failed to
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demonstrate a relationship between the number of a given
streptococcal species circulating immediately after teeth
extraction and the likelihood of these streptococci subse-
quently producing endocarditis'131. Indeed, some strepto-
coccal strains found in the blood at barely detectable levels
consistently produced endocarditis, while other viridans
streptococci found in much higher numbers in the blood
only rarely infected the valves. In these experiments, the
parameter that best predicted the likelihood of a strain
producing endocarditis was the in vitro adherence of the
strain to platelet-fibrin matrices'13'. Thus, the determina-
tion of the magnitude of the bacteraemia alone may not
provide reliable information on the risk of subsequent
development of bacterial endocarditis after certain proce-
dures. Finally, quantitative blood cultures obtained from
rats after the i.v. injection of lCHcfu of either Streptococcus
intermedius or S. faecalis (corresponding approximately to
the ID50 and ID90 of the two microorganisms, respectively)
showed that the magnitude of the bacteraemia was in the
range of 102 cfu.mr1 at 5 min'12'. These data are similar to
those reported in humans after certain invasive procedures
such as teeth extraction'"1. Occasionally, figures of 103
cfu.mr1 have been documented. The relationship between
the magnitude of the bacteraemia and the subsequent risk
of developing endocarditis is unknown in humans. It may
well be that the very few patients who will develop endo-
carditis after procedures are precisely those with the high-
est number of circulating bacteria or those with bacteria
with high adherence properties. Thus, some countries have
elected to recommend a high dose of amoxicillin 1 hour
before the procedure followed by one or several additional
doses a few hours later15'6'.
Inhibitory and bactericidal activity of the antibiotics
It is still believed by some authors that the protective
effect of the antibiotics in the prophylaxis of endocarditis is
due to the bactericidal action of the antibiotic, and that
high serum levels at the time of bacteraemia should pro-
vide optimal bactericidal activity and protection. There are
several lines of evidence which suggest that the bactericidal
activity is not the main mechanism of action of antibiotics
in endocarditis prophylaxis. First, when carefully tested in
vitro, many strains of viridans streptococci as well as en-
terococci are tolerant to the bactericidal action of amoxi-
cillin'14'. Nevertheless, amoxicillin is effective in preventing
experimental endocarditis due to these strains'9121. Second,
antibiotics also provide protection when administered after
bacterial challenge, clearly showing that the prophylactic
effect is not due to a bactericidal activity on the circulating
bacteria1151. Thus, other mechanisms of action have to be
considered and experiments suggest that antibiotics oper-
ate in inhibiting of the growth of the bacteria stuck to the
vegetations, thereby allowing other elimination mechan-
isms to operate112'. This concept is based on the following
observations: after bacterial challenge, a small proportion
of the circulating bacteria will adhere to the vegetations
within the first few minutes, but they will tend to disappear
spontaneously from the valves even in the absence of
antibiotics1121. However, if too many bacteria have adhered
their spontaneous elimination will be overcome by the
growth of the bacteria, and endocarditis will occur. If
growth can be retarded by an inhibitory concentration of
antibiotics, elimination will continue and endocarditis may
be prevented if all adherent bacteria have been cleared
before bacterial growth resumes. The higher the inoculum
(i.e. the higher the amount of adherent bacteria), the more
prolonged the inhibitory concentration of antibiotics to
prevent endocarditis should be1'21.
This concept was confirmed in recent experiments which
compared the efficacy of sustained low versus short high
blood levels of amoxicillin in the prevention of streptococ-
cal endocarditis in the rat. Results showed that amoxicillin
administered as a continuous infusion over 12 h was
significantly more effective than an i.v. bolus of the same
amount of the antibiotic (antibiotic no longer detectable
in the serum at 6 h). Moreover, a low dose of amoxicillin
was equally as active as a high dose when administered
continuously over 12 h1161.
Thus, bacterial growth inhibition mediated by the pres-
ence of inhibitory concentration of antibiotics over several
hours could be an important preventive mechanism of the
antibiotics in allowing bacterial clearance of resting organ-
isms at the surface of the vegetations by as yet undefined
host defence factors. Platelets have been shown to contain
bactericidal substances. Since they are major constituents
of the vegetations, they may play an important adjuvant
role in killing the bacteria present at the surface of a vege-
tation1171.
From animals to humans
The arguments for the single dose regimen in humans
have been the following: an oral dose of 3 g of amoxicillin
taken 30 min before a procedure produces serum levels at
the time of the procedure which are much higher than the
minimal inhibitory and bactericidal concentrations of most
potential pathogens circulating in the blood. In addition,
serum levels are detectable for at least 6 hours Such an
oral dose is easy to administer, well tolerated and should
ensure optimal compliance. Experimentally, in conditions
mimicking single dose amoxicillin prophylaxis, protection
was afforded for inocula infecting 90% of control animals;
it is therefore likely to provide a good margin of safety in
humans since the number of circulating bacteria during an
invasive procedure is usually very low. This approach has
been chosen by The Netherlands, U.K. and France.
In contrast, some authorities recommend that patients at
risk for endocarditis take a high dose of amoxicillin before
an invasive procedure as well as one or several additional
doses in order to cover the possibility that the heart valves
may have been seeded by a rather high number of bacteria.
The experimental data described above suggest that such an
approach is likely to provide a higher margin of safety. The
American Heart Association recommends one additional
dose of amoxicillin for all patients. The present Swiss and
German recommendations distinguish between patients at
low and high risk for endocarditis. For those at high risk
(prosthetic valves, prior endocarditis), seven additional
doses of amoxicillin are presently recommended161.
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